{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Kyunggon Kim"}, {"accession": "MS:1000589", "name": "contact email", "value": "kimkyunggon@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Asan Medical Center"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Kyunggon Kim"}, {"accession": "MS:1000589", "name": "contact email", "value": "kimkyunggon@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Asan Medical Center, Clinical Proteomics Core, Republic of Korea"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20130411_DK_13_044_01_T177phospho_Trypsin.RAW"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190611_SDM_TFCP2L1_E01.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190726_ShinDM_Mixture_E01.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190726_ShinDM_TF_CDK1_ATP2_05nm_E01.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190806_T177A_1_E01.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190806_T177A_Control_E01.raw"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/CDK1_in vitro_kinase_assay_ATP2_05nm_1.1.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/CDK1_in vitro_kinase_assay_mixture_1.1.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/FCPL21_Human_Blabber_cancer_1.1.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/FCPL21_In vitro_kinase_assay_1_1.1.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/FCPL21_In vitro_kinase_assay_Cont_1.1.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/TFCP2L1_Mouse_1.1.mzid.gz"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20130411_DK_13_044_01_T177phospho_Trypsin.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190611_SDM_TFCP2L1_E01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190726_ShinDM_Mixture_E01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190726_ShinDM_TF_CDK1_ATP2_05nm_E01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190806_T177A_1_E01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635/20190806_T177A_Control_E01.mgf"}], "description": "Molecular programs involved in embryogenesis are frequently upregulated in oncogenic   dedifferentiation and metastasis. However, their precise roles and regulatory mechanisms remain elusive. Here, we showed that CDK1 phosphorylation of TFCP2L1, a pluripotency-associated transcription factor, orchestrated pluripotency and cell-cycling in embryonic stem cells (ESCs) and was aberrantly activated in aggressive bladder cancers (BCs). In murine ESCs, the protein interactome and transcription targets of Tfcp2l1 indicated its involvement in cell-cycle regulation. Tfcp2l1 was phosphorylated at Thr177 by Cdk1, which affected ESC cell-cycle progression, pluripotency, and differentiation. LC-MS was used to characterize thr177 phosphorylation in TFCP2L1 protein obtained by IP experiment and kinase assay. The CDK1-TFCP2L1 pathway was activated in human BC cells, stimulating their proliferation, self-renewal, and invasion. Lack of TFCP2L1 phosphorylation impaired the tumorigenic potency of BC cells in a xenograft model. In patients with BC, high co-expression of TFCP2L1 and CDK1 was associated with unfavorable clinical characteristics including tumor grade, lymphovascular and muscularis propria invasion, and distant metastasis and was an independent prognostic factor for cancer specific survival. These findings demonstrate the molecular and clinical significance of CDK1-mediated TFCP2L1 phosphorylation in stem-cell pluripotency and in the tumorigenic stemness features associated with BC progression.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD015635"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD015635"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD015635"}, {"accession": "MS:1001922", "name": "Digital Object Identifier (DOI)", "value": "10.6019/PXD015635"}], "instruments": [{"accession": "MS:1000447", "name": "LTQ"}, {"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Bladder cancer, CDK1, embryonic stem-cell, pluripotency, stemness features"}], "modifications": [{"accession": "UNIMOD:385", "name": "Ammonia-loss"}, {"accession": "UNIMOD:21", "name": "Phospho"}, {"accession": "UNIMOD:30", "name": "Cation:Na"}, {"accession": "UNIMOD:27", "name": "Glu->pyro-Glu"}, {"accession": "UNIMOD:35", "name": "Oxidation"}, {"accession": "UNIMOD:1", "name": "Acetyl"}, {"accession": "UNIMOD:4", "name": "Carbamidomethyl"}, {"accession": "UNIMOD:28", "name": "Gln->pyro-Glu"}], "publications": [{"terms": [{"accession": "MS:1002858", "name": "Dataset with its publication pending"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mus musculus (Mouse)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10090"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Identification of CDK1 phosphorylation of TFCP2L1 from murine embryonic stem cells and bladder cancer cells"}